Asker Healthcare Group AB (Ticker: ASKER SS), a Swedish company operating in the medical labs and testing services industry, plans to list on the Stockholm Stock Exchange on March 27, 2025. The IPO offering consists of 126.95 million shares (21.43 million primary and 105.52 million secondary) at a fixed price of SEK 70 (USD 6.85), aiming to raise SEK 8.89 billion (USD 869.14 million). An overallotment option of 19.04 million shares also exists. The IPO could give the company an implied market valuation of SEK 26.8 billion (approximately USD 2.6 billion). Cornerstone investors have committed to acquiring shares worth SEK 5.8 billion. Majority owner Nalka Invest AB intends to retain a majority stake. The company intends to use about SEK 1.2 from IPO proceeds billion to refinance existing credit facilities. BNP Paribas, Carnegie, Citi, Danske Bank and Nordea are managing the offering.